Traws Pharma Revenue vs. Price To Book
| TRAW Stock | 5.02 0.31 5.82% |
Total Revenue | First Reported 2010-12-31 | Previous Quarter 203.4 K | Current Value 193.2 K | Quarterly Volatility 959.9 K |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 1.03 | 0.9292 |
|
|
For Traws Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Traws Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Traws Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Traws Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Traws Pharma over time as well as its relative position and ranking within its peers.
Traws |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Traws Pharma. If investors know Traws will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Traws Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.95) | Revenue Per Share 0.01 | Return On Assets (0.53) | Return On Equity (10.97) |
The market value of Traws Pharma is measured differently than its book value, which is the value of Traws that is recorded on the company's balance sheet. Investors also form their own opinion of Traws Pharma's value that differs from its market value or its book value, called intrinsic value, which is Traws Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Traws Pharma's market value can be influenced by many factors that don't directly affect Traws Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Traws Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Traws Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Traws Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Traws Pharma Price To Book vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Traws Pharma's current stock value. Our valuation model uses many indicators to compare Traws Pharma value to that of its competitors to determine the firm's financial worth. Traws Pharma is currently regarded number one company in revenue category among its peers. It also is currently regarded as top stock in price to book category among its peers . The ratio of Revenue to Price To Book for Traws Pharma is about 134,966 . At this time, Traws Pharma's Total Revenue is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Traws Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Traws Revenue vs. Competition
Traws Pharma is currently regarded number one company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 40.2 Billion. Traws Pharma adds roughly 226,000 in revenue claiming only tiny portion of equities under Health Care industry.
Traws Price To Book vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Traws Pharma |
| = | 226 K |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Traws Pharma |
| = | 1.67 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Traws Price To Book Comparison
Traws Pharma is currently under evaluation in price to book category among its peers.
Traws Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Traws Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Traws Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Traws Pharma's change in net profit over the period of time. It can combine multiple indicators of Traws Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -23 K | -24.1 K | |
| Operating Income | -20.3 M | -21.3 M | |
| Income Before Tax | -18.9 M | -19.9 M | |
| Total Other Income Expense Net | 1.4 M | 1.4 M | |
| Net Loss | -18.9 M | -19.9 M | |
| Income Tax Expense | -151.9 K | -159.5 K | |
| Net Loss | -18.9 M | -19.9 M | |
| Net Loss | (0.90) | (0.95) | |
| Income Quality | 0.95 | 0.70 | |
| Net Income Per E B T | 1.15 | 1.10 |
Traws Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Traws Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Traws Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Traws Pharma's important profitability drivers and their relationship over time.
Use Traws Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Traws Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will appreciate offsetting losses from the drop in the long position's value.Traws Pharma Pair Trading
Traws Pharma Pair Trading Analysis
The ability to find closely correlated positions to Traws Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Traws Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Traws Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Traws Pharma to buy it.
The correlation of Traws Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Traws Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Traws Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Traws Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Traws Pharma position
In addition to having Traws Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.